Cheal, Sarah M.
Xu, Hong
Guo, Hong-fen
Lee, Sang-gyu
Punzalan, Blesida
Chalasani, Sandhya
Fung, Edward K.
Jungbluth, Achim
Zanzonico, Pat B.
Carrasquillo, Jorge A.
O’Donoghue, Joseph
Smith-Jones, Peter M.
Wittrup, K. Dane
Cheung, Nai-Kong V.
Larson, Steven M.
Funding for this research was provided by:
National Institutes of Health (R01-CA-101830)
National Institutes of Health (P50-CA86438)
National Institutes of Health (1 S10 RR028889-01)
Article History
Received: 31 July 2015
Accepted: 2 November 2015
First Online: 24 November 2015
Compliance with ethical standards
:
: This study was supported in part by the following: Donna & Benjamin M. Rosen Chair (to S.M. Larson), Enid A. Haupt Chair (to N.K. Cheung), The Center for Targeted Radioimmunotherapy and Theranostics, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center (to S.M. Larson), a training grant from the National Institutes of Health (R25-CA096945; principal investigator H. Hricak, fellow S.M. Cheal), and a National Institutes of Health grant (R01-CA-101830; to K.D. Wittrup). S.M. Larson was also supported in part by P50-CA86438. Technical services provided by the Memorial Sloan Kettering Small-Animal Imaging Core Facility were supported by National Institutes of Health grants R24-CA83084 (to H. Hricak), P30-CA08748 (to C. Thompson), and P50-CA92629 (to H. Scher). National Institutes of Health Shared Instrumentation grant No. 1 S10 RR028889-01 (to P.B. Zanzonico), and a Shared Resources Grant from the Memorial Sloan Kettering Cancer Center Metastasis Research Center (to P. B. Zanzonico), which provided funding support for the purchase of the Focus 120 microPET and the NanoSPECT/CT Plus, respectively, are gratefully acknowledged.
: None.
: All animal experiments were approved by the Institutional Animal Care and Use Committee of Memorial Sloan Kettering Cancer Center, and institutional guidelines for the proper and humane use of animals in research were followed.